Form 4: AvePoint Director Jeff Epstein Sells 500,000 Shares in Planned Transaction

AvePoint, Inc. Director Jeff Epstein executed a pre-planned sale of 500,000 shares of common stock at $18.77 per share, reducing his direct beneficial ownership to 1,157,891 shares.

Summary

• Jeff Epstein, a Director of AvePoint, Inc. (AVPT), disposed of 500,000 shares of the company's common stock.
• The transaction occurred on June 2, 2025, at a price of $18.77 per share.
• This sale was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan, indicating it was pre-scheduled.
• Following this transaction, Mr. Epstein directly beneficially owns 1,157,891 shares of AvePoint common stock.
• The remaining beneficial ownership includes non-RSU common stock and unvested Restricted Stock Units (RSUs) subject to a previously reported vesting schedule from a Form 4 filed on June 4, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While a director selling shares can be perceived negatively, the fact that it's a pre-planned 10b5-1 transaction mitigates immediate concerns, suggesting it's part of a personal financial management strategy rather than a reaction to adverse company news.

Negatives

• A director selling a significant number of shares, even if pre-planned, can sometimes be perceived negatively by investors as it might suggest a lack of confidence, although this is not necessarily the case with 10b5-1 plans.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing reports a routine insider transaction by a director of AvePoint, Inc., a software company. Such transactions are common and often executed under pre-arranged 10b5-1 plans, which allow insiders to sell shares at predetermined times to avoid accusations of trading on material non-public information. This specific transaction does not provide broader industry context.

Stakeholder Impact

• Shareholders: The sale by a director could lead to minor concerns about insider confidence, but the 10b5-1 plan context suggests it's a routine event. The reduction in direct beneficial ownership is noted.

Key Dates

Recommendation

Keywords

AvePoint, AVPT, Jeff Epstein, Insider Trading, Form 4, Stock Sale, Director, Beneficial Ownership, 10b5-1 Plan